Radioiodine uptake after monotherapy with potassium iodide in patients with Graves’ disease

The effect of potassium iodide (KI) on radioiodine uptake (RAIU) before radioisotope therapy in Graves’ disease (GD) patients was investigated. A total of 82 patients who had been treated with KI monotherapy before 24-hour RAIU (24 h RAIU) were evaluated and 354 of those who had been treated with th...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Endocrine Journal 2023, Vol.70(5), pp.541-549
Hauptverfasser:	Mikura, Kentaro, Noh, Jaeduk Yoshimura, Watanabe, Natsuko, Aida, Azusa, Yoshimura, Ran, Kinoshita, Aya, Suzuki, Ai, Suzuki, Nami, Fukushita, Miho, Matsumoto, Masako, Yoshihara, Ai, Sugino, Kiminori, Ito, Koichi
Format:	Artikel
Sprache:	eng
Schlagworte:	Excretion Female Graves disease Graves Disease - drug therapy Graves Disease - radiotherapy Humans Iodine Iodine Radioisotopes - therapeutic use Methimazole - therapeutic use Multiple regression analysis Potassium Potassium iodide Potassium Iodide - therapeutic use Radioisotope uptake Radioisotopes Regression analysis Thiamazole Urinary iodine excretion
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The effect of potassium iodide (KI) on radioiodine uptake (RAIU) before radioisotope therapy in Graves’ disease (GD) patients was investigated. A total of 82 patients who had been treated with KI monotherapy before 24-hour RAIU (24 h RAIU) were evaluated and 354 of those who had been treated with thiamazole (MMI) monotherapy were extracted from the 1,130 GD patients who were identified as having had appropriate iodine restriction based on urinary iodine excretion. Urinary iodine excretion (UIE)
ISSN:	0918-8959 1348-4540
DOI:	10.1507/endocrj.EJ22-0505